Trials & R&D · first seen yesterday, updated yesterday
How China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies
GlobalData briefing: China biopharma drives global licensing growth, platform acquisitions, amid tightening US scrutiny. The post How China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies appeared first on Cli…
Summary from Clinical Trials Arena.
Coverage 4 articles · 2 outlets
-
Clinical Trials ArenaHow China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies
-
Pharmaceutical TechnologyHow China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies
-
Clinical Trials ArenaHow China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies
-
Clinical Trials ArenaHow China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies